Cargando…

Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations

Nanostructured lipid carriers (NLCs) loaded with lopinavir (LPV) were prepared by the high-shear homogenization method. The LPV-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. In vitro release studies in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Arshad Ali, Mudassir, Jahanzeb, Akhtar, Safia, Murugaiyah, Vikneswaran, Darwis, Yusrida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410192/
https://www.ncbi.nlm.nih.gov/pubmed/30823545
http://dx.doi.org/10.3390/pharmaceutics11020097
_version_ 1783402184977678336
author Khan, Arshad Ali
Mudassir, Jahanzeb
Akhtar, Safia
Murugaiyah, Vikneswaran
Darwis, Yusrida
author_facet Khan, Arshad Ali
Mudassir, Jahanzeb
Akhtar, Safia
Murugaiyah, Vikneswaran
Darwis, Yusrida
author_sort Khan, Arshad Ali
collection PubMed
description Nanostructured lipid carriers (NLCs) loaded with lopinavir (LPV) were prepared by the high-shear homogenization method. The LPV-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. In vitro release studies in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8) showed a burst release. The optimized freeze-dried formulation (LPV-NLC-7-Tres) had a particle size (PS), polydispersity index (PdI), zeta potential (ZP) and % entrapment efficiency (%EE) of 286.8 ± 1.3 nm, 0.413 ± 0.017, −48.6 ± 0.89 mV and 88.31 ± 2.04%, respectively. The optimized formulation observed by transmission and scanning electron microscopes showed a spherical shape. Differential scanning calorimetry study revealed the absence of chemical interaction between the drug and lipids. In vitro cellular uptake study using Caco-2 cell line showed a higher LPV uptake from LPV-NLC-7-Tres formulation compared to the free LPV-suspension. The 6-month stability study showed a minimum rise of ~40 nm in PS, while no significant changes in PdI, ZP and drug content of the LPV-NLC-7-Tres formulation stored at 5 °C ± 3 °C. The bioavailability of LPV following oral administration of LPV-NLC-7-Tres in male Wistar rats was found 6.98-fold higher than the LPV-suspension. In conclusion, the nanostructure lipid carriers are potential carriers for improving the oral bioavailability of lopinavir.
format Online
Article
Text
id pubmed-6410192
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64101922019-03-29 Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations Khan, Arshad Ali Mudassir, Jahanzeb Akhtar, Safia Murugaiyah, Vikneswaran Darwis, Yusrida Pharmaceutics Article Nanostructured lipid carriers (NLCs) loaded with lopinavir (LPV) were prepared by the high-shear homogenization method. The LPV-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. In vitro release studies in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8) showed a burst release. The optimized freeze-dried formulation (LPV-NLC-7-Tres) had a particle size (PS), polydispersity index (PdI), zeta potential (ZP) and % entrapment efficiency (%EE) of 286.8 ± 1.3 nm, 0.413 ± 0.017, −48.6 ± 0.89 mV and 88.31 ± 2.04%, respectively. The optimized formulation observed by transmission and scanning electron microscopes showed a spherical shape. Differential scanning calorimetry study revealed the absence of chemical interaction between the drug and lipids. In vitro cellular uptake study using Caco-2 cell line showed a higher LPV uptake from LPV-NLC-7-Tres formulation compared to the free LPV-suspension. The 6-month stability study showed a minimum rise of ~40 nm in PS, while no significant changes in PdI, ZP and drug content of the LPV-NLC-7-Tres formulation stored at 5 °C ± 3 °C. The bioavailability of LPV following oral administration of LPV-NLC-7-Tres in male Wistar rats was found 6.98-fold higher than the LPV-suspension. In conclusion, the nanostructure lipid carriers are potential carriers for improving the oral bioavailability of lopinavir. MDPI 2019-02-25 /pmc/articles/PMC6410192/ /pubmed/30823545 http://dx.doi.org/10.3390/pharmaceutics11020097 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khan, Arshad Ali
Mudassir, Jahanzeb
Akhtar, Safia
Murugaiyah, Vikneswaran
Darwis, Yusrida
Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
title Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
title_full Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
title_fullStr Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
title_full_unstemmed Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
title_short Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations
title_sort freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: statistical optimization, in vitro and in vivo evaluations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410192/
https://www.ncbi.nlm.nih.gov/pubmed/30823545
http://dx.doi.org/10.3390/pharmaceutics11020097
work_keys_str_mv AT khanarshadali freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations
AT mudassirjahanzeb freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations
AT akhtarsafia freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations
AT murugaiyahvikneswaran freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations
AT darwisyusrida freezedriedlopinavirloadednanostructuredlipidcarriersforenhancedcellularuptakeandbioavailabilitystatisticaloptimizationinvitroandinvivoevaluations